Cargando…

Histamine H(1) antagonist levocetirizine as a potential cause of lung injury

Histamine H(1) antagonists rarely cause drug-induced lung injury (DLI). A woman in her 60s, who had been taking antihistaminic levocetirizine for 2 months, presented with progressive cough and shortness of breath. A chest radiograph showed patchy infiltrations on both lower lung fields. Chest comput...

Descripción completa

Detalles Bibliográficos
Autores principales: Endo, Satoshi, Yamamoto, Yasushi, Minami, Yoshinori, Okumura, Shunsuke, Sasaki, Takaaki, Ohsaki, Yoshinobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469143/
https://www.ncbi.nlm.nih.gov/pubmed/26090114
http://dx.doi.org/10.1002/rcr2.101
_version_ 1782376596122894336
author Endo, Satoshi
Yamamoto, Yasushi
Minami, Yoshinori
Okumura, Shunsuke
Sasaki, Takaaki
Ohsaki, Yoshinobu
author_facet Endo, Satoshi
Yamamoto, Yasushi
Minami, Yoshinori
Okumura, Shunsuke
Sasaki, Takaaki
Ohsaki, Yoshinobu
author_sort Endo, Satoshi
collection PubMed
description Histamine H(1) antagonists rarely cause drug-induced lung injury (DLI). A woman in her 60s, who had been taking antihistaminic levocetirizine for 2 months, presented with progressive cough and shortness of breath. A chest radiograph showed patchy infiltrations on both lower lung fields. Chest computed tomography findings were consistent with non-specific interstitial pneumonia. Serum markers associated with interstitial pneumonias were elevated. Room air arterial blood gas analysis revealed hypoxemia. Restrictive ventilatory impairment was noted with reduced diffusing capacity. Transbronchial lung biopsy specimens demonstrated unclassifiable alveolitis. Steroid pulse therapy was introduced for respiratory distress, but the initial response to treatment was poor. A drug lymphocyte stimulation test was positive for levocetirizine. The interstitial pneumonia improved following withdrawal of levocetirizine. Her illness has not recurred under steroid therapy and the discontinuation of levocetirizine. Antihistaminics may have a potential risk of DLI.
format Online
Article
Text
id pubmed-4469143
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-44691432015-06-18 Histamine H(1) antagonist levocetirizine as a potential cause of lung injury Endo, Satoshi Yamamoto, Yasushi Minami, Yoshinori Okumura, Shunsuke Sasaki, Takaaki Ohsaki, Yoshinobu Respirol Case Rep Case Reports Histamine H(1) antagonists rarely cause drug-induced lung injury (DLI). A woman in her 60s, who had been taking antihistaminic levocetirizine for 2 months, presented with progressive cough and shortness of breath. A chest radiograph showed patchy infiltrations on both lower lung fields. Chest computed tomography findings were consistent with non-specific interstitial pneumonia. Serum markers associated with interstitial pneumonias were elevated. Room air arterial blood gas analysis revealed hypoxemia. Restrictive ventilatory impairment was noted with reduced diffusing capacity. Transbronchial lung biopsy specimens demonstrated unclassifiable alveolitis. Steroid pulse therapy was introduced for respiratory distress, but the initial response to treatment was poor. A drug lymphocyte stimulation test was positive for levocetirizine. The interstitial pneumonia improved following withdrawal of levocetirizine. Her illness has not recurred under steroid therapy and the discontinuation of levocetirizine. Antihistaminics may have a potential risk of DLI. BlackWell Publishing Ltd 2015-06 2015-04-09 /pmc/articles/PMC4469143/ /pubmed/26090114 http://dx.doi.org/10.1002/rcr2.101 Text en © 2015 The Authors. Respirology Case Reports published by John Wiley & Sons Ltd on behalf of The Asian Pacific Society of Respirology. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Endo, Satoshi
Yamamoto, Yasushi
Minami, Yoshinori
Okumura, Shunsuke
Sasaki, Takaaki
Ohsaki, Yoshinobu
Histamine H(1) antagonist levocetirizine as a potential cause of lung injury
title Histamine H(1) antagonist levocetirizine as a potential cause of lung injury
title_full Histamine H(1) antagonist levocetirizine as a potential cause of lung injury
title_fullStr Histamine H(1) antagonist levocetirizine as a potential cause of lung injury
title_full_unstemmed Histamine H(1) antagonist levocetirizine as a potential cause of lung injury
title_short Histamine H(1) antagonist levocetirizine as a potential cause of lung injury
title_sort histamine h(1) antagonist levocetirizine as a potential cause of lung injury
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469143/
https://www.ncbi.nlm.nih.gov/pubmed/26090114
http://dx.doi.org/10.1002/rcr2.101
work_keys_str_mv AT endosatoshi histamineh1antagonistlevocetirizineasapotentialcauseoflunginjury
AT yamamotoyasushi histamineh1antagonistlevocetirizineasapotentialcauseoflunginjury
AT minamiyoshinori histamineh1antagonistlevocetirizineasapotentialcauseoflunginjury
AT okumurashunsuke histamineh1antagonistlevocetirizineasapotentialcauseoflunginjury
AT sasakitakaaki histamineh1antagonistlevocetirizineasapotentialcauseoflunginjury
AT ohsakiyoshinobu histamineh1antagonistlevocetirizineasapotentialcauseoflunginjury